ARP-1536 Anti-VEGF bispecific antibody(Aerpio Pharmaceuticals)

N/A

Report date: 2025/04/09 15:47:13

Base Information

Drug NameARP-1536 Anti-VEGF bispecific antibody(Aerpio Pharmaceuticals)

Drug Alias NameARP-1536-AV

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionProtein tyrosine phosphatase inhibitorsVascular endothelial growth factor inhibitors

TargetsProtein tyrosine phosphataseVascular endothelial growth factor

Therapy Area/IndicationsDiabetic macular oedemaMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesWhitehawk Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesWhitehawk Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsDiabetic macular oedemaMacular Degeneration

Inactive IndicationsN/A

Other Information

ATC CodeN/A